$20.26
-0.1-0.49%
At close: -
$20.26
00.00%
After Hours: 4:00 PM EDT
Bicycle Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bicycle Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $-0.74 | $-0.78 | 5.13 % |
Jun 2024 | 2024-08-06 | $-0.77 | $-1.14 | 32.5 % |
Mar 2024 | 2024-05-02 | $-0.62 | $-1.24 | 50.0 % |
Dec 2023 | 2024-02-20 | $-1.16 | $-1.23 | 5.69 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $2.68M | $6.84M | -60.9 % |
Jun 2024 | 2024-08-06 | $9.36M | $6.17M | 51.7 % |
Mar 2024 | 2024-05-02 | $19.53M | $6.03M | 223.9 % |
Dec 2023 | 2024-02-20 | $5.33M | $7.14M | -25.3 % |
Bicycle Therapeutics (BCYC) is scheduled to report earnings on February 18, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.
The Actual EPS was $-0.74, which beat the estimate of $-0.78.
The Actual Revenue was $2.7M, which missed the estimate of $6.8M.
Browse earnings estimates, EPS, and revenue on all stocks.